🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ACTHAR is a FDA approved drug for MS relapses. The purpose of the study is ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-20
Trial ID
NCT03021317
Treatments Being Tested
This is a Rheumatoid Arthritis (RA) study. The purpose of this research stu...
Status
Completed
Location
UCLA David Geffen School of Medicine, Division of Rheumatology
Start Date
2017-07-20
Trial ID
NCT02541955
Treatments Being Tested
The purpose of this study is to evaluate the effect of adrenocorticotropic ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2018-03-19
Trial ID
NCT03025828
Treatments Being Tested
To determine if H.P. Acthar Gel (repository corticotrophin) has the same an...
Status
Completed
Location
AKDHC
Start Date
2009-12
Trial ID
NCT01021540
Treatments Being Tested
This will be a prospective observational study of Acthar Gel in Non-Diabeti...
Status
Terminated
Location
Center for Dialysis Care 3695 Stutz Drive
Start Date
2015-03
Trial ID
NCT02486744
Treatments Being Tested
The purpose of this pilot study is to assess repository corticotropin injec...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2018-11-01
Trial ID
NCT03398018
Treatments Being Tested
This study will determine changes in: 1) the immune activity, characterized...
Status
Unknown
Location
Tanner Center for MS
Start Date
2013-08
Trial ID
NCT01906684
Treatments Being Tested
The purpose of this pilot study is to assess the safety and efficacy of Act...
Status
Withdrawn
Location
Phoenix Neurological Associates
Start Date
2015-08
Trial ID
NCT02574962
Treatments Being Tested
This study will enroll about 66 participants who experienced a relapse of R...
Status
Terminated
Location
Stanford University Medical Center
Start Date
2017-05-22
Trial ID
NCT03126760
Treatments Being Tested
The purpose of this study is to compare intramuscular (IM) ACTH (adrenocort...
Status
Terminated
Location
Neurologique Foundation, Inc.
Start Date
2009-10
Trial ID
NCT00947895
Treatments Being Tested